Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4′-tri-O-acetylresveratrol in rats

Phytomedicine

Volumn 20, Issue 6, 2013, Pages 558-563

  Liang, Li ^a   Liu, Xueying ^a   Wang, Qingwei ^a   Cheng, Sikun ^a   Zhang, Shengyong ^a   Zhang, Meng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

3,5,4 Tri O acetylresveratrol; Excretion; HPLC; Pharmacokinetics; Resveratrol; Tissue distribution

Indexed keywords

3,5,4 TRI O ACETYLRESVERATROL; HYDROXYL GROUP; PRODRUG; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EXCRETION; DRUG FECES LEVEL; DRUG LIVER LEVEL; DRUG SYNTHESIS; DRUG TISSUE LEVEL; DRUG TRANSFORMATION; DRUG URINE LEVEL; ENTERIC FEEDING; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TISSUE DISTRIBUTION;

ANIMALS; AREA UNDER CURVE; FECES; HALF-LIFE; HEART; LIVER; LUNG; MALE; MYOCARDIUM; PRODRUGS; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; STILBENES; TISSUE DISTRIBUTION;

RATTUS;

EID: 84875948396     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2012.12.012     Document Type: Article

References (16)

1. Chan, A.S.C., Chen, S.L., Li, Y., Yang, D., 2004. Puerarin derivatives and their medical uses. Google Patents.
2. D. Delmas, B. Jannin, and N. Latruffe Resveratrol: preventing properties against vascular alterations and ageing Molecular Nutrition & Food Research 49 2005 377 395
3. S. Dore Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity Neuro-signals 14 2005 61 70
4. M. Fontecave, M. Lepoivre, E. Elleingand, C. Gerez, and O. Guittet Resveratrol, a remarkable inhibitor of ribonucleotide reductase FEBS Letters 421 1998 277 279
5. E. Fragopoulou, T. Nomikos, H.C. Karantonis, C. Apostolakis, E. Pliakis, M. Samiotaki, G. Panayotou, and S. Antonopoulou Biological activity of acetylated phenolic compounds Journal of Agricultural and Food Chemistry 55 2007 80 89
6. S.K. Goswami, and D.K. Das Resveratrol and chemoprevention Cancer Letters 284 2009 1 6
7. R.W. Hill, and P.W. Holland Corrigenda: two robust alternatives to least-squares regression Journal of the American Statistical Association 73 1978 455
8. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
9. K. Koide, S. Osman, A.L. Garner, F. Song, T. Dixon, J.S. Greenberger, and M.W. Epperly The use of 3,5,4′-tri-O-acetylresveratrol as a potential prodrug for resveratrol protects mice from γ-irradiation-induced death ACS Medicinal Chemistry Letters 2 2011 270 274
10. A. Lancon, D. Delmas, H. Osman, J.P. Thenot, B. Jannin, and N. Latruffe Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process Biochemical and Biophysical Research Communications 316 2004 1132 1137
11. A.A. Nanji, and S.W. French Alcoholic beverages and coronary heart disease Atherosclerosis 60 1986 197 198
12. J.A. Parker, M. Arango, S. Abderrahmane, E. Lambert, C. Tourette, H. Catoire, and C. Neri Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons Nature Genetics 37 2005 349 350
13. J.L. Richard Coronary risk factors. The French paradox Archives des Maladies du Coeur et des Vaisseaux 80 Spec No 1987 17 21
14. E. Wenzel, T. Soldo, H. Erbersdobler, and V. Somoza Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats Molecular Nutrition & Food Research 49 2005 482 494
15. E. Wenzel, and V. Somoza Metabolism and bioavailability of trans-resveratrol Molecular Nutrition & Food Research 49 2005 472 481
16. J. Zhu, W. Yong, X. Wu, Y. Yu, J. Lv, C. Liu, X. Mao, Y. Zhu, K. Xu, X. Han, and C. Liu Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes Biochemical and Biophysical Research Communications 369 2008 471 477